3750 — ADR Biomedical Holdings Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 308.89 | ||
| Price to Tang. Book | 308.89 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 133.43 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -221.02% | ||
| Return on Equity | -121.65% | ||
| Operating Margin | -612.67% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 1,335.58 | 2,144.71 | 1,560.39 | 122.2 | 50.99 | n/a | n/a | -48.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sapporo Breweries Ltd, formerly Sapporo Holdings Ltd, is a Japan-based company mainly engaged in the operation of alcoholic beverage and food and beverage businesses. The Company consists of two business segments. The Alcoholic Beverage segment manufactures and sells beer, sparkling wine, wine, and other alcoholic beverages, and sells wine and other spirits in stores and through mail order. It also operates various types of restaurants, including Lion Chain beer halls and restaurants. The Food and Beverage segment manufactures and sells drinking water and food products.
Directors
- Last Annual
- March 31st, 2026
- Last Interim
- March 31st, 2026
- Incorporated
- October 1st, 2004
- Public Since
- October 1st, 2004
- No. of Shareholders
- 8,224
- No. of Employees
- 13
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 8,928,099
- Address
- 9F, CHIYODA-KU, 102-0083
- Web
- https://adr.co.jp
- Phone
- +81 362619067
- Auditors
- Audit Firm HIBISCUS
Latest News for 3750
Upcoming Events for 3750
Q2 2027 ADR Biomedical Holdings Inc. Earnings Release
Dividend For 3750.T - 0.0000 JPY
Similar to 3750
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
As of Today at 01:05 UTC, shares in ADR Biomedical Holdings are trading at ¥762. This share price information is delayed by 15 minutes.
Shares in ADR Biomedical Holdings last closed at ¥762 and the price had moved by -7.86% over the past 365 days. In terms of relative price strength the ADR Biomedical Holdings share price has underperformed the Nikkei 225 Index by -31.9% over the past year.
There is no consensus recommendation for this security.
Find out moreADR Biomedical Holdings does not currently pay a dividend.
ADR Biomedical Holdings does not currently pay a dividend.
ADR Biomedical Holdings does not currently pay a dividend.
To buy shares in ADR Biomedical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥762, shares in ADR Biomedical Holdings had a market capitalisation of ¥7bn.
Here are the trading details for ADR Biomedical Holdings:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 3750
Based on an overall assessment of its quality, value and momentum ADR Biomedical Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ADR Biomedical Holdings. Over the past six months, its share price has underperformed the Nikkei 225 Index by -16.93%.
As of the last closing price of ¥762, shares in ADR Biomedical Holdings were trading -7.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ADR Biomedical Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥762.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ADR Biomedical Holdings' management team is headed by:
- Hirotaka Todo - PRE
- Yukio Murai - EXO
- Yuji Seki - OTH
- Fuminori Nakashima - IND